ES529068A0 - Un procedimiento para la preparacion de fenotiazonas halogenadas. - Google Patents
Un procedimiento para la preparacion de fenotiazonas halogenadas.Info
- Publication number
- ES529068A0 ES529068A0 ES529068A ES529068A ES529068A0 ES 529068 A0 ES529068 A0 ES 529068A0 ES 529068 A ES529068 A ES 529068A ES 529068 A ES529068 A ES 529068A ES 529068 A0 ES529068 A0 ES 529068A0
- Authority
- ES
- Spain
- Prior art keywords
- phenothiazes
- halogenated
- procedure
- preparation
- halogenated phenothiazes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D293/00—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
- C07D293/10—Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C46/00—Preparation of quinones
- C07C46/02—Preparation of quinones by oxidation giving rise to quinoid structures
- C07C46/06—Preparation of quinones by oxidation giving rise to quinoid structures of at least one hydroxy group on a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/46—Phenazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/38—[b, e]-condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/34—[b, e]-condensed with two six-membered rings with hetero atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/36—[b, e]-condensed, at least one with a further condensed benzene ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45992483A | 1983-01-21 | 1983-01-21 | |
US53648783A | 1983-09-28 | 1983-09-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8607256A1 ES8607256A1 (es) | 1986-06-16 |
ES529068A0 true ES529068A0 (es) | 1986-06-16 |
Family
ID=27039516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES529068A Expired ES8607256A1 (es) | 1983-01-21 | 1984-01-20 | Un procedimiento para la preparacion de fenotiazonas halogenadas. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0115394B1 (es) |
AU (1) | AU561698B2 (es) |
CA (1) | CA1262544A (es) |
DE (1) | DE3478788D1 (es) |
DK (1) | DK20884A (es) |
ES (1) | ES8607256A1 (es) |
GR (1) | GR81709B (es) |
IL (1) | IL70656A (es) |
NZ (1) | NZ206795A (es) |
PT (1) | PT77957B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3484745D1 (de) * | 1983-10-05 | 1991-08-01 | Merck Frosst Canada Inc | Inhibitoren fuer die leukotrien-biosynthese. |
EP0136893B1 (en) * | 1983-10-05 | 1989-08-16 | Merck Frosst Canada Inc. | Benzo[a]phenothiazines and hydro-derivatives and pharmaceutical compositions containing them |
EP0155623A3 (en) * | 1984-03-19 | 1985-12-27 | Merck & Co. Inc. | Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition |
DE3411574A1 (de) * | 1984-03-29 | 1985-10-10 | Boehringer Mannheim Gmbh, 6800 Mannheim | Glycoside von resorufin-derivaten, verfahren zu deren herstellung sowie deren verwendung zur bestimmung der aktivitaet von glycosidasen |
US4728735A (en) * | 1984-10-15 | 1988-03-01 | Merck & Co., Inc. | 10,11-dihydro-dibenzo-[b,f][1,4]-thiazepin derivatives |
DE3516001A1 (de) * | 1985-05-03 | 1986-11-06 | Boehringer Mannheim Gmbh, 6800 Mannheim | Lipasefarbtest |
CA1309557C (en) | 1985-06-18 | 1992-10-27 | Robert N. Young | Leukotriene antagonists |
EP0239306B1 (en) | 1986-03-27 | 1993-06-02 | Merck Frosst Canada Inc. | Tetrahydrocarbazole esters |
EP0480716A1 (en) | 1990-10-12 | 1992-04-15 | Merck Frosst Canada Inc. | Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
US5500760A (en) * | 1991-09-06 | 1996-03-19 | Donnelly Corporation | Electrochemichromic solutions, processes for preparing and using the same, and devices manufactured with the same |
US5910854A (en) | 1993-02-26 | 1999-06-08 | Donnelly Corporation | Electrochromic polymeric solid films, manufacturing electrochromic devices using such solid films, and processes for making such solid films and devices |
EP0612826B1 (en) * | 1993-02-26 | 2000-10-04 | Donnelly Corporation | Electrochromic polymeric solid films, manufacturing electrochromic devices using such solid films, and processing for making such solid films and devices |
US5410054A (en) * | 1993-07-20 | 1995-04-25 | Merck Frosst Canada, Inc. | Heteroaryl quinolines as inhibitors of leukotriene biosynthesis |
US7446924B2 (en) | 2003-10-02 | 2008-11-04 | Donnelly Corporation | Mirror reflective element assembly including electronic component |
EP1685117B1 (en) | 2003-10-31 | 2015-01-07 | Life Technologies Corporation | Fluorinated resorufin compounds and their application in detecting hydrogen peroxide |
CN101973946B (zh) * | 2010-10-15 | 2012-12-12 | 上海交通大学 | 吩嗪-1-羧酸系列衍生物及其制备方法 |
US9670170B2 (en) | 2013-03-15 | 2017-06-06 | Bioelectron Technology Corporation | Resorufin derivatives for treatment of oxidative stress disorders |
US9868711B2 (en) * | 2013-03-15 | 2018-01-16 | Bioelectron Technology Corporation | Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders |
US9296712B2 (en) | 2013-03-15 | 2016-03-29 | Edison Pharmaceuticals, Inc. | Resorufin derivatives for treatment of oxidative stress disorders |
WO2016013009A1 (en) * | 2014-07-21 | 2016-01-28 | B. G. Negev Technologies And Applications Ltd. (Ben-Gurion University) | Phenothiazine/phenothiazone -graphene oxide composite |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4427588Y1 (es) * | 1965-04-05 | 1969-11-17 |
-
1984
- 1984-01-10 NZ NZ206795A patent/NZ206795A/en unknown
- 1984-01-11 IL IL70656A patent/IL70656A/xx not_active IP Right Cessation
- 1984-01-11 GR GR73485A patent/GR81709B/el unknown
- 1984-01-13 PT PT77957A patent/PT77957B/pt unknown
- 1984-01-13 AU AU23269/84A patent/AU561698B2/en not_active Ceased
- 1984-01-16 EP EP84300239A patent/EP0115394B1/en not_active Expired
- 1984-01-16 DE DE8484300239T patent/DE3478788D1/de not_active Expired
- 1984-01-18 DK DK20884A patent/DK20884A/da not_active Application Discontinuation
- 1984-01-20 ES ES529068A patent/ES8607256A1/es not_active Expired
- 1984-01-20 CA CA000445812A patent/CA1262544A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IL70656A (en) | 1988-05-31 |
PT77957A (en) | 1984-02-01 |
DK20884A (da) | 1984-07-22 |
AU561698B2 (en) | 1987-05-14 |
ES8607256A1 (es) | 1986-06-16 |
GR81709B (es) | 1984-12-12 |
DE3478788D1 (en) | 1989-08-03 |
DK20884D0 (da) | 1984-01-18 |
EP0115394A3 (en) | 1985-01-30 |
IL70656A0 (en) | 1984-04-30 |
EP0115394A2 (en) | 1984-08-08 |
CA1262544A (en) | 1989-10-31 |
PT77957B (en) | 1986-06-18 |
EP0115394B1 (en) | 1989-06-28 |
AU2326984A (en) | 1984-07-26 |
NZ206795A (en) | 1987-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES539625A0 (es) | Un procedimiento para la preparacion de derivados de fenetano. | |
ES528627A0 (es) | Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas. | |
ES512882A0 (es) | Un procedimiento para la preparacion de agentes antifugicos triazolicos. | |
ES523858A0 (es) | Un procedimiento para la preparacion de benzotienil benzofuranil o naftil-derivados. | |
ES530364A0 (es) | Un procedimiento para la preparacion de un nucleosido. | |
ES533753A0 (es) | Un procedimiento para la preparacion de nuevas fenoxialquil-1-2-4-triazolonas. | |
ES511123A0 (es) | Un procedimiento para la preparacion de un dihidroxi-compuesto. | |
ES534892A0 (es) | Un procedimiento para la preparacion de derivados de penem-2-metil sustituidos. | |
ES536525A0 (es) | Un procedimiento para la preparacion de derivados de fenotiazinas. | |
ES535953A0 (es) | Un procedimiento para la preparacion de derivados 3-cefem-4-carboxilicos. | |
ES529068A0 (es) | Un procedimiento para la preparacion de fenotiazonas halogenadas. | |
ES530418A0 (es) | Un procedimiento para la preparacion de pirazolopiridinas. | |
ES511124A0 (es) | Un procedimiento para la preparacion de un dihidroxi-compuesto. | |
ES538907A0 (es) | Un procedimiento para la preparacion de derivados enol-eteres de oxicanis. | |
ES536455A0 (es) | Un procedimiento para la preparacion de un antibiotico bbm-2478. | |
ES534607A0 (es) | Un procedimiento para la preparacion de un derivado de poliol-eter. | |
ES529846A0 (es) | Un procedimiento para la preparacion de derivados benzoheterociclicos. | |
ES511663A0 (es) | Un procedimiento para la preparacion de un heteropoliacido. | |
ES522120A0 (es) | Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles. | |
ES514311A0 (es) | Un procedimiento para la preparacion de benzofurasulfamatos. | |
ES509312A0 (es) | Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona. | |
ES511665A0 (es) | Un procedimiento para la preparacion de fenilaminoimidazolidinas. | |
ES509432A0 (es) | Un procedimiento para la preparacion de arilaminas. | |
ES531792A0 (es) | Un procedimiento para la preparacion de un compuesto. | |
ES529213A0 (es) | Un procedimiento para la preparacion de derivados de isoquinuclidina. |